Description
Tesamorelin is the full 44-residue sequence of growth-hormone-releasing hormone, with an N-terminal trans-3-hexenoyl modification that protects it from rapid enzymatic breakdown.
Research context
It is a reference GHRH-receptor agonist in research on pituitary GH secretion and on the GH/IGF-1 axis.
Specifications
| Amount per vial | 10 mg or 20 mg (choose above) |
|---|---|
| Form | Lyophilized (freeze-dried) powder in a sealed glass vial |
| Storage | Store sealed vials at −20 °C, away from light. Once reconstituted, keep at 2–8 °C. |
| Intended use | In-vitro and laboratory research only |
For laboratory research use only. Not for human or veterinary use, and not a drug, food, cosmetic or supplement. Sold only to qualified researchers who accept our Research Use Policy.
Reviews
There are no reviews yet.